FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

FOCUS ON RESEARCH Previous Volume 355:1522-1523 October 12, 2006 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Oeffinger, K. C. PubMed Citation

In the June 3, 1948, issue of the Journal, Sydney Farber and his colleagues reported that they had successfully used aminopterin to induce temporary remission in children with lymphoid leukemia. This exciting article suggested that what had been a uniformly fatal disease might be amenable to treatment and, some dared to hope, cure. Then, in 1970, DeVita and his colleagues at the National Cancer Institute showed that a combination of non–cross-reactive chemotherapeutic agents, the MOPP regimen (mechlorethamine, vincristine, procarbazine, and prednisone), could induce sustained remission in advanced Hodgkin's disease. From such beginnings, an extraordinary success story unfolded, and today, more . . . [Full Text of this Article]

Source Information

Dr. Rosoff is an associate professor of pediatric hematology–oncology at Duke University School of Medicine and director of the Duke University Hospital Program in Clinical Ethics, Durham, NC.

Related Letters:

Survivors of Childhood Cancer
Goodwin T., Oosterhuis B. E., Hayes-Lattin B., the LIVESTRONG Young Adult Alliance , Sharma N., Melgar T., Brands C., Haupt R., Jankovic M., Veerman A. J.P., the International Berlin–Frankfurt–Münster Early and Late Toxicity Educational Committee , Oeffinger K. C., Sklar C. A., Robison L. L., Rosoff P. M.
Extract | Full Text | PDF  
N Engl J Med 2007; 356:191-194, Jan 11, 2007. Correspondence

This article has been cited by other articles:

• Dantonello, T. M., Int-Veen, C., Harms, D., Leuschner, I., Schmidt, B. F., Herbst, M., Juergens, H., Scheel-Walter, H.-G., Bielack, S. S., Klingebiel, T., Dickerhoff, R., Kirsch, S., Brecht, I., Schmelzle, R., Greulich, M., Gadner, H., Greiner, J., Marky, I., Treuner, J., Koscielniak, E. (2009). Cooperative Trial CWS-91 for Localized Soft Tissue Sarcoma in Children, Adolescents, and Young Adults. JCO 27: 1446-1455 [Abstract] [Full Text]  
• Phipps, S. (2007). Adaptive Style in Children with Cancer: Implications for a Positive Psychology Approach. J Pediatr Psychol 32: 1055-1066 [Abstract] [Full Text]  
• Goodwin, T., Oosterhuis, B. E., Hayes-Lattin, B., the LIVESTRONG Young Adult Alliance, , Sharma, N., Melgar, T., Brands, C., Haupt, R., Jankovic, M., Veerman, A. J.P., the International Berlin-Frankfurt-Munster Early a, , Oeffinger, K. C., Sklar, C. A., Robison, L. L., Rosoff, P. M. (2007). Survivors of Childhood Cancer. NEJM 356: 191-194 [Full Text]  
• (2006). Adult Survivors of Childhood Cancer. JWatch Pediatrics 2006: 1-1 [Full Text]  
• (2006). Adult Survivors of Childhood Cancer. JWatch General 2006: 3-3 [Full Text]